Elke Leupolt

4.2k total citations · 1 hit paper
11 papers, 2.9k citations indexed

About

Elke Leupolt is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Elke Leupolt has authored 11 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 10 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Elke Leupolt's work include Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Viral-associated cancers and disorders (3 papers). Elke Leupolt is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Viral-associated cancers and disorders (3 papers). Elke Leupolt collaborates with scholars based in Germany, United Kingdom and United States. Elke Leupolt's co-authors include Peter Lichter, Stephan Stilgenbauer, Hartmut Döhner, Axel Benner, Martin Bentz, Alexander Kröber, Lars Bullinger, Konstanze Döhner, Dirk Winkler and Claudia Schaffner and has published in prestigious journals such as New England Journal of Medicine, Blood and Annals of Oncology.

In The Last Decade

Elke Leupolt

11 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia

2000 2.3k citations Hartmut Döhner, Stephan Stilgenbauer et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Elke Leupolt

Since Specialization

Citations

This map shows the geographic impact of Elke Leupolt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke Leupolt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke Leupolt more than expected).

Fields of papers citing papers by Elke Leupolt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elke Leupolt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke Leupolt. The network helps show where Elke Leupolt may publish in the future.

Co-authorship network of co-authors of Elke Leupolt

This figure shows the co-authorship network connecting the top 25 collaborators of Elke Leupolt. A scholar is included among the top collaborators of Elke Leupolt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elke Leupolt. Elke Leupolt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations 2008 ·Haematologica ·Sandrine Sander, Lars Bullinger, Elke Leupolt, Axel Benner, Dirk Kienle, Tiemo Katzenberger, Jörg Kalla, G. Ott, H K Müller‐Hermelink, Teresa Barth, Peter Mӧller, Peter Lichter, Hartmut Döhner, Stephan Stilgenbauer	33
2	Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival 2007 ·Haematologica ·Stephan Stilgenbauer, Sandrine Sander, Lars Bullinger, Axel Benner, Elke Leupolt, Dirk Winkler, Alexander Kröber, Dirk Kienle, Peter Lichter, H. Döhner	153
3	Clonal Evolution in Chronic Lymphocytic Leukemia: Acquisition of High-Risk Genomic Aberrations Associated with Unmutated VH, Resistance to Therapy, and Short Survival. 2006 ·Blood ·Stephan Stilgenbauer, Sandrine Sander, Lars Bullinger, Axel Benner, Elke Leupolt, Dirk Winkler, Alexander Kröber, Dirk Kienle, Peter Lichter, Hartmut Döhner	10
4	VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome 2003 ·Blood ·Dirk Kienle, Alexander Kröber, Tiemo Katzenberger, German Ott, Elke Leupolt, Thomas F.E. Barth, Peter Möller, Axel Benner, (unknown), Hans Konrad Müller‐Hermelink, Martin Bentz, Peter Lichter, Hartmut Döhner, Stephan Stilgenbauer	102
5	Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes 2002 ·Blood ·(unknown), Armin Pscherer, Axel Benner, Daniel Mertens, Claudia Schaffner, Elke Leupolt, Hartmut Döhner, Stephan Stilgenbauer, Peter Lichter	116
6	Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia breakdown → 2000 ·New England Journal of Medicine ·Hartmut Döhner, Stephan Stilgenbauer, Axel Benner, Elke Leupolt, Alexander Kröber, Lars Bullinger, Konstanze Döhner, Martin Bentz, Peter Lichter	2266
7	BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma 2000 ·Leukemia ·Lars Bullinger, Elke Leupolt, Claudia Schaffner, Daniel Mertens, Martin Bentz, Peter Lichter, Hartmut Döhner, Stephan Stilgenbauer	13
8	The ATM gene in the pathogenesis of mantle-cell lymphoma 2000 ·Annals of Oncology ·Stephan Stilgenbauer, Claudia Schaffner, Dirk Winkler, German Ott, Elke Leupolt, Martin Bentz, Peter Mӧller, H. K. Müller-Hermelink, Michael R. James, Peter Lichter, Hartmut Döhner	30
9	Molecular Characterization of 11q Deletions Points to a Pathogenic Role of the ATM Gene in Mantle Cell Lymphoma 1999 ·Blood ·Stephan Stilgenbauer, Dirk Winkler, German Ott, Claudia Schaffner, Elke Leupolt, Martin Bentz, Peter Mӧller, Hans Konrad Müller‐Hermelink, Michael R. James, Peter Lichter, Hartmut Döhner	82
10	Molecular Characterization of 11q Deletions Points to a Pathogenic Role of the ATM Gene in Mantle Cell Lymphoma 1999 ·Blood ·Stephan Stilgenbauer, Dirk Winkler, German Ott, Claudia Schaffner, Elke Leupolt, Martin Bentz, Peter Mӧller, Hans Konrad Müller‐Hermelink, Michael R. James, Peter Lichter, Hartmut Döhner	89
11	Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization. 1995 ·PubMed ·Stephan Stilgenbauer, Elke Leupolt, (unknown), (unknown), Martin Schröder, Konstanze Fischer, Martin Bentz, Peter Lichter, Hartmut Döhner	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact